Claudia Cavada

Abbott agrees to acquire Latin America’s CFR Pharmaceuticals for $2.9bn

American pharmaceuticals & health care products firm Abbott Laboratories on Friday confirmed that it would acquire Chile-based CFR Pharmaceuticals SA in a $2.9 billion (£1.72 billion) deal.

Abbott will acquire nearly 73 per cent of CFR's publicly traded shares from founder Weinstein family-led holding company, while a tender offer will be issued for buying the remaining shares.

Subscribe to RSS - Claudia Cavada